Barclays’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.3M Buy
677,913
+508,423
+300% +$13.2M 0.01% 1014
2025
Q4
$3.37M Buy
169,490
+72,304
+74% +$1.39M ﹤0.01% 2536
2025
Q3
$1.77M Sell
97,186
-51,835
-35% -$853K ﹤0.01% 2965
2025
Q2
$2.35M Buy
149,021
+59,642
+67% +$758K ﹤0.01% 2718
2025
Q1
$1.13M Sell
89,379
-5,574
-6% -$87.5K ﹤0.01% 3030
2024
Q4
$2.09M Buy
94,953
+59,308
+166% +$1.25M ﹤0.01% 2838
2024
Q3
$635K Buy
+35,645
New +$571K ﹤0.01% 3628
2024
Q2
Sell
-517
Closed -$7.68K 4926
2024
Q1
$7.68K Sell
517
-31,974
-98% -$509K ﹤0.01% 4832
2023
Q4
$581K Sell
32,491
-168,379
-84% -$2.73M ﹤0.01% 3789
2023
Q3
$3.84M Buy
200,870
+55,370
+38% +$959K ﹤0.01% 1498
2023
Q2
$2.31M Buy
145,500
+106,470
+273% +$1.75M ﹤0.01% 1798
2023
Q1
$678K Buy
39,030
+34,399
+743% +$611K ﹤0.01% 3040
2022
Q4
$78.2K Buy
+4,631
New +$74.7K ﹤0.01% 4370
2022
Q1
Sell
-151
Closed -$2K 5019
2021
Q4
$2K Sell
151
-136,958
-100% -$1.72M ﹤0.01% 4045
2021
Q3
$1.08M Buy
137,109
+136,300
+16,848% +$938K ﹤0.01% 2742
2021
Q2
$6K Hold
809
﹤0.01% 4727
2021
Q1
$5K Hold
809
﹤0.01% 4480
2020
Q4
$3K Hold
809
﹤0.01% 4798
2020
Q3
$2K Sell
809
-15,298
-95% -$39.3K ﹤0.01% 5120
2020
Q2
$37K Buy
16,107
+3,915
+32% +$8.37K ﹤0.01% 5042
2020
Q1
$13K Sell
12,192
-16,958
-58% -$57.3K ﹤0.01% 5750
2019
Q4
$106K Sell
29,150
-60,415
-67% -$209K ﹤0.01% 5451
2019
Q3
$326K Buy
89,565
+32,909
+58% +$141K ﹤0.01% 4596
2019
Q2
$238K Sell
56,656
-19,096
-25% -$76.4K ﹤0.01% 4957
2019
Q1
$270K Buy
75,752
+43,440
+134% +$144K ﹤0.01% 4597
2018
Q4
$71K Sell
32,312
-130,846
-80% -$540K ﹤0.01% 5259
2018
Q3
$1.04M Sell
163,158
-28,729
-15% -$204K ﹤0.01% 3577
2018
Q2
$1.43M Sell
191,887
-21,843
-10% -$164K ﹤0.01% 2893
2018
Q1
$1.51M Buy
213,730
+100,045
+88% +$739K ﹤0.01% 2756
2017
Q4
$875K Sell
113,685
-10,126
-8% -$84.4K ﹤0.01% 3243
2017
Q3
$1.03M Buy
123,811
+14,293
+13% +$89K ﹤0.01% 2967
2017
Q2
$465K Sell
109,518
-2,606
-2% -$10.5K ﹤0.01% 3597
2017
Q1
$426K Buy
112,124
+53,992
+93% +$214K ﹤0.01% 3555
2016
Q4
$233K Sell
58,132
-13,457
-19% -$54.9K ﹤0.01% 4094
2016
Q3
$323K Sell
71,589
-8,485
-11% -$43.7K ﹤0.01% 3590
2016
Q2
$392K Sell
80,074
-8,205
-9% -$46.5K ﹤0.01% 3403
2016
Q1
$971K Sell
88,279
-26,162
-23% -$364K ﹤0.01% 2557
2015
Q4
$2.17M Sell
114,441
-25,521
-18% -$630K ﹤0.01% 1963
2015
Q3
$3.36M Buy
139,962
+380
+0.3% +$9.87K ﹤0.01% 1653
2015
Q2
$3.49M Sell
139,582
-672,607
-83% -$17.8M ﹤0.01% 1768
2015
Q1
$19.5M Buy
812,189
+666,166
+456% +$16.9M 0.02% 691
2014
Q4
$3.21M Buy
146,023
+19,427
+15% +$506K ﹤0.01% 2094
2014
Q3
$3.42M Buy
126,596
+67,208
+113% +$2.03M ﹤0.01% 2145
2014
Q2
$1.84M Buy
59,388
+51,955
+699% +$1.55M ﹤0.01% 2688
2014
Q1
$186K Sell
7,433
-18,064
-71% -$493K ﹤0.01% 4858
2013
Q4
$663K Buy
25,497
+5,020
+25% +$140K ﹤0.01% 3818
2013
Q3
$553K Buy
20,477
+2,136
+12% +$67.1K ﹤0.01% 4004
2013
Q2
$667K Buy
+18,341
New +$659K ﹤0.01% 3882

Other funds holding CLMT

Barclays's CLMT Position: Q1 2026 in Review

Barclays increased its Calumet Specialty Products (CLMT) stake by 300% in Q1 2026, buying an estimated $13.2M and bringing the position to 677,913 shares worth $24.3M. The position accounts for 0.01% of the portfolio, ranked #1014.

Barclays first reported a position in CLMT in Q2 2013 and has held it in 48 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Barclays held 677,913 shares of Calumet Specialty Products worth $24.3M as of Q1 2026.
  • Barclays bought 508,423 Calumet Specialty Products shares in Q1 2026, an estimated $13.2M.
  • Calumet Specialty Products made up 0.01% of Barclays's portfolio in Q1 2026, its #1014 holding.
  • Barclays first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 48 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.